About Precision for Medicine
Precision for Medicine is a company based in Bethesda (United States) founded in 2013. Precision for Medicine has raised $150 million across 3 funding rounds from investors including TPG, J.H. Whitney Capital Partners and Oak Investment Partners. Precision for Medicine offers products and services including CRO Services, Lab Services, and Biospecimens. Precision for Medicine operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
- Headquarter Bethesda, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Precision Medicine Group, Llc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$150 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
TPG
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Precision for Medicine
Precision for Medicine offers a comprehensive portfolio of products and services, including CRO Services, Lab Services, and Biospecimens.
Manages trials for drug development and patient recruitment.
Performs immune monitoring and genomics for research support.
Provides collections for therapeutic area studies and diagnostics.
People of Precision for Medicine
Unlock access to complete
Leadership Team
89 people
Senior Team
36 people
Software Development Team
35 people
Operations Team
24 people
Principal Team
16 people
Sales and Marketing
15 people
Finance and Accounting
14 people
Product Management Team
13 people
Unlock access to complete
Funding Insights of Precision for Medicine
Precision for Medicine has successfully raised a total of $150M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(02 Apr 2013)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2015 | Amount | Private Equity Round - Precision for Medicine | Valuation |
investors |
|
| Jan, 2015 | Amount | Grant - Precision for Medicine | Valuation |
investors |
|
| Apr, 2013 | Amount | Private Equity Round - Precision for Medicine | Valuation |
investors |
Investors in Precision for Medicine
Precision for Medicine has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include TPG, J.H. Whitney Capital Partners and Oak Investment Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Fund of funds focused on pre-seed and seed-stage companies
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in disruptive growth companies.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Precision for Medicine
Financial Statements - Precision for Medicine
Precision For Medicine Comparisons
Competitors of Precision for Medicine
Precision for Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of drug discovery and preclinical development services
|
|
| domain | founded_year | HQ Location |
Provider of laboratory tests for physicians
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| domain | founded_year | HQ Location |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
Frequently Asked Questions about Precision for Medicine
Precision for Medicine was founded in 2013.
Precision for Medicine is headquartered in Bethesda, United States. It is registered at Bethesda, Maryland, United States.
Precision for Medicine is a funded company, having raised a total of $150M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $150M, raised on Apr 02, 2013.
Precision for Medicine is a part of the Precision for Medicine Group along with Precision for Value (Offering market access and outcomes services) and Precision Effect (offering branding and engagement services). Precision For Medicine is a specialised services company supporting pharmaceutical and life sciences companies in the development of precision medicine in RD. The company offers specialised biomarker, laboratory, and clinical trial services as well as the necessary regulatory expertise to facilitate the research and development of precision medicine based drugs and devices. They have a team of scientists, clinical trial professionals and technical specialists who offer their services for biomarker (with focus on oncology biomarkers) identification through analysis of omics and clinical data, integrated and global clinical trial services, biorepository and specialty laboratory (including custom assay development, including molecular, cellular and immunological assays) services , companion diagnostic product development, regulatory solutions and IVD and medical device studies. The company acquired ACT Oncology (now Precision Oncology, an Oncology CRO) and Applied Immunology (a bioanalytical CRO developing, validating and implementing cell-based and immunological assays for drug development) to boost its offerings.
Precision for Medicine's top competitors include LabCorp, Charles River Laboratories and Cytel.
Precision for Medicine offers CRO Services, Lab Services, and Biospecimens.
Precision for Medicine has 3 investors. Key investors include TPG, J.H. Whitney Capital Partners, and Oak Investment Partners.